RESUMO
An estimated ratio (i.e., 1 in 10) babies are born too early every year. Roughly 1 million children die each year due to impediments raised pertaining to preterm birth. One such extreme preterm male baby was presented in the neonatal care unit with respiratory distress and grunting. Baby was confirmed to have ventricular septal defect along with patent ductus arteriosus and craniosynostosis which was treated with medications and surgical managements. He was also engaged with various prophylactic and empirical antibiotic therapies to cover the microbial growth. The most disturbing stage here was the appearance of liver mass sizing 5.8 cm × 1.3 cm accompanied with area of necrosis, diagnosed with hepatoblastoma which was evident with the aid of ultrasound. Hence, chemotherapy was commenced which was in accordance with Societe Internationale d Oncologie Pediatrique Epithelial Liver Tumor Study Group-3. Although the existing comorbidities haunted the baby for a long time, he finally made it successfully to get into track by fighting all the hurdles bravely, which was a sheer miracle. Along with the clinicians/surgeons, we Clinical Pharmacists worked hand in hand to ensure the baby to be receiving optimized drug regimen keeping in mind the risk-benefit ratio.
RESUMO
Multiple Sclerosis (MS) is a chronic progressive disease with a variety of cognitive, motor and sensory deficits. It is characterised by demyelination of axons of the brain and spinal cord where the patient presents with the complaints of blurred or double vision, lack of coordination, loss of balance, numbness and tremors throughout the body or extremities with weakness, muscle spasms etc. In Ayurveda, Multiple Sclerosis can be correlated to Snayusada or the aggravation of Vata in Snayu. Modern treatments like immunosuppressant, corticosteroids, stem cell therapy are highly expensive when compared to Ayurvedic management. The scope of Ayurvedic Management and preventive aspects mainly concentrates on improving the quality of life and decrease dependency of patients. The objective of this review is to evaluate the clinical utility of the Ayurvedic medicines for Multiple Sclerosis. Clinical trials by Ayurvedic experts suggest that Ayurvedic treatment processes and preventive measures (Life style management and recommended diet) may reduce the risk of Multiple Sclerosis. Here I briefly explain the current literature of Multiple Sclerosis, modern and Ayurvedic views, Ayurvedic medicines usually given in Multiple Sclerosis cases with a focus on designing prevention and treatment protocol.